Annual Operating Profit
-$68.51 M
-$8.00 M-13.23%
31 December 2023
Summary:
Lexeo Therapeutics Common Stock annual operaing income is currently -$68.51 million, with the most recent change of -$8.00 million (-13.23%) on 31 December 2023. During the last 3 years, it has fallen by -$17.88 million (-35.30%). LXEO annual operating profit is now -1393.37% below its all-time high of -$4.59 million, reached on 01 December 2020.LXEO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$31.54 M
-$7.99 M-33.94%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock quarterly operating income is currently -$31.54 million, with the most recent change of -$7.99 million (-33.94%) on 30 September 2024. Over the past year, it has dropped by -$16.57 million (-110.65%). LXEO quarterly operating profit is now -125.71% below its all-time high of -$13.97 million, reached on 30 June 2023.LXEO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$93.36 M
-$11.27 M-13.73%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock TTM operating income is currently -$93.36 million, with the most recent change of -$11.27 million (-13.73%) on 30 September 2024. Over the past year, it has dropped by -$24.85 million (-36.27%). LXEO TTM operating profit is now -509.74% below its all-time high of -$15.31 million, reached on 30 June 2022.LXEO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXEO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -110.7% | -36.3% |
| 3 y3 years | -35.3% | - | - |
| 5 y5 years | - | - | - |
LXEO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.3% | at low | -125.7% | at low | -509.7% | at low |
| 5 y | 5 years | -1393.4% | at low | -125.7% | at low | -509.7% | at low |
| alltime | all time | -1393.4% | at low | -125.7% | at low | -509.7% | at low |
Lexeo Therapeutics Common Stock Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$31.54 M(+33.9%) | -$93.36 M(+13.7%) |
| June 2024 | - | -$23.55 M(+1.1%) | -$82.09 M(+13.2%) |
| Mar 2024 | - | -$23.29 M(+55.5%) | -$72.51 M(+5.8%) |
| Dec 2023 | -$68.51 M | -$14.97 M(-26.1%) | -$68.51 M(-0.3%) |
| Sept 2023 | - | -$20.27 M(+45.1%) | -$68.73 M(+4.2%) |
| June 2023 | - | -$13.97 M(-27.6%) | -$65.94 M(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$19.29 M(+26.9%) | -$67.28 M(+40.2%) |
| Dec 2022 | -$60.51 M(+19.5%) | -$15.20 M(-13.1%) | -$47.99 M(+46.3%) |
| Sept 2022 | - | -$17.48 M(+14.2%) | -$32.79 M(+114.2%) |
| June 2022 | - | -$15.31 M | -$15.31 M |
| Dec 2021 | -$50.64 M(+1003.7%) | - | - |
| Dec 2020 | -$4.59 M | - | - |
FAQ
- What is Lexeo Therapeutics Common Stock annual operaing income?
- What is the all time high annual operating profit for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock quarterly operating income?
- What is the all time high quarterly operating profit for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock quarterly operating profit year-on-year change?
- What is Lexeo Therapeutics Common Stock TTM operating income?
- What is the all time high TTM operating profit for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock TTM operating profit year-on-year change?
What is Lexeo Therapeutics Common Stock annual operaing income?
The current annual operating profit of LXEO is -$68.51 M
What is the all time high annual operating profit for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high annual operaing income is -$4.59 M
What is Lexeo Therapeutics Common Stock quarterly operating income?
The current quarterly operating profit of LXEO is -$31.54 M
What is the all time high quarterly operating profit for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high quarterly operating income is -$13.97 M
What is Lexeo Therapeutics Common Stock quarterly operating profit year-on-year change?
Over the past year, LXEO quarterly operating income has changed by -$16.57 M (-110.65%)
What is Lexeo Therapeutics Common Stock TTM operating income?
The current TTM operating profit of LXEO is -$93.36 M
What is the all time high TTM operating profit for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high TTM operating income is -$15.31 M
What is Lexeo Therapeutics Common Stock TTM operating profit year-on-year change?
Over the past year, LXEO TTM operating income has changed by -$24.85 M (-36.27%)